Jiangsu Desenuo Pharmaceutical

Jiangsu Desenuo Pharmaceutical is a specialized pharmaceutical company located in the China Medical City (CMC) in Taizhou, Jiangsu Province. The company primarily focuses on the research, development, and large-scale production of high-end active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, particularly in the field of oncology. Its product portfolio includes key molecules such as Ibrutinib, Enzalutamide, and Lenvatinib, catering to both domestic and international markets. Desenuo operates modern manufacturing facilities that adhere to stringent quality management systems. The company also provides custom synthesis and contract manufacturing services to global pharmaceutical partners.